BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25775477)

  • 1. Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid.
    Shimizu-Motohashi Y; Asakura Y; Motohashi N; Belur NR; Baumrucker MG; Asakura A
    PLoS One; 2015; 10(3):e0120325. PubMed ID: 25775477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
    Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
    Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.
    Cea LA; Puebla C; Cisterna BA; Escamilla R; Vargas AA; Frank M; Martínez-Montero P; Prior C; Molano J; Esteban-Rodríguez I; Pascual I; Gallano P; Lorenzo G; Pian H; Barrio LC; Willecke K; Sáez JC
    Cell Mol Life Sci; 2016 Jul; 73(13):2583-99. PubMed ID: 26803842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
    Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ
    Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin ameliorates dystrophic phenotype in mdx mouse skeletal muscle.
    Eghtesad S; Jhunjhunwala S; Little SR; Clemens PR
    Mol Med; 2011; 17(9-10):917-24. PubMed ID: 21607286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
    Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
    Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment.
    González-Sánchez J; Sánchez-Temprano A; Cid-Díaz T; Pabst-Fernández R; Mosteiro CS; Gallego R; Nogueiras R; Casabiell X; Butler-Browne GS; Mouly V; Relova JL; Pazos Y; Camiña JP
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1063-1078. PubMed ID: 30216693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aquaporins in skeletal muscle: reassessment of the functional role of aquaporin-4.
    Frigeri A; Nicchia GP; Balena R; Nico B; Svelto M
    FASEB J; 2004 May; 18(7):905-7. PubMed ID: 15033928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype.
    Galbiati F; Volonte D; Chu JB; Li M; Fine SW; Fu M; Bermudez J; Pedemonte M; Weidenheim KM; Pestell RG; Minetti C; Lisanti MP
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9689-94. PubMed ID: 10931944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
    Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
    Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers.
    Quinlan JG; Wong BL; Niemeier RT; McCullough AS; Levin L; Emanuele M
    Neuromuscul Disord; 2006 Dec; 16(12):855-64. PubMed ID: 17118658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementation with a selective amino acid formula ameliorates muscular dystrophy in mdx mice.
    Banfi S; D'Antona G; Ruocco C; Meregalli M; Belicchi M; Bella P; Erratico S; Donato E; Rossi F; Bifari F; Lonati C; Campaner S; Nisoli E; Torrente Y
    Sci Rep; 2018 Oct; 8(1):14659. PubMed ID: 30279586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.
    Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S
    Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated MMP2 abundance and activity in mdx mice are alleviated by prenatal taurine supplementation.
    Ren X; Xu H; Barker RG; Lamb GD; Murphy RM
    Am J Physiol Cell Physiol; 2020 Jun; 318(6):C1083-C1091. PubMed ID: 32208990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice.
    Spencer MJ; Tidball JG
    Exp Cell Res; 1996 Aug; 226(2):264-72. PubMed ID: 8806430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cells of extraembryonic mesodermal origin confer human dystrophin in the mdx model of Duchenne muscular dystrophy.
    Kawamichi Y; Cui CH; Toyoda M; Makino H; Horie A; Takahashi Y; Matsumoto K; Saito H; Ohta H; Saito K; Umezawa A
    J Cell Physiol; 2010 Jun; 223(3):695-702. PubMed ID: 20162617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle.
    Farini A; Sitzia C; Cassinelli L; Colleoni F; Parolini D; Giovanella U; Maciotta S; Colombo A; Meregalli M; Torrente Y
    Development; 2016 Feb; 143(4):658-69. PubMed ID: 26884398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
    Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
    Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.